FDA FY2020 Drug Inspection Observations and Trends
A comprehensive GMP intelligence program includes monitoring health authority enforcement actions. The actions include FDA Form 483s, Establishment Inspection Reports, warning letters, recalls, import alerts, consent decree agreements, MHRA annual summaries of inspection deficiencies, and EU reports of GMDP noncompliance. This article presents the most recent publication of GMP drug inspection data, which address drug […]